Filing identity and reporting period
Important: Despite the request metadata naming Spectral AI, Inc., this filing is Rosecliff Acquisition Corp I’s Form 10-K for the fiscal year ended December 31, 2022. It does not report Spectral AI’s results. Rosecliff was a shell SPAC seeking a business combination, not an operating company.
Business context and material developments
Rosecliff raised $253.0 million in its February 2021 IPO and initially placed $253.0 million in its trust account. Its proposed combination with Gett was terminated by mutual agreement on March 11, 2022, after the parties reviewed financial projections and could not agree on an appropriate valuation adjustment. The company said it would continue seeking a target.
At a December 21, 2022 special meeting, stockholders extended the business-combination deadline from February 17, 2023 to February 17, 2024 and removed the charter’s redemption limitation. Stockholders also elected to redeem 24,841,284 public shares, about 98.2% of the shares then outstanding; the filing reports $250.5 million distributed in connection with those redemptions. At year-end, 458,716 Class A shares remained outstanding and subject to possible redemption.
Financial results and liquidity
| Metric | 2022 | 2021 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expenses | $1.251 million | $3.421 million |
| Net income (loss) | $11.039 million | ($2.148 million) |
| Cash used in operating activities | $1.019 million | $0.826 million |
| Trust-account interest income | $3.156 million | $0.027 million |
The 2022 net income was not operating profit: it principally reflected a $9.748 million noncash gain from the change in fair value of warrant liabilities and $3.156 million of trust interest, partly offset by operating costs and $0.614 million of income-tax expense. The filing gives no operating revenue or operating margin because the company had no operations.
At December 31, 2022, cash outside the trust was $785,038, prepaid expenses were $153,575, and trust-account cash was $4.626 million. Current liabilities were $3.624 million, including $3.352 million of accrued expenses and $255,297 of income taxes payable. Warrant liabilities were $394,200 and deferred underwriting fees payable were $8.855 million; the filing reports no long-term debt. Management reports a working-capital deficit of $2.847 million in MD&A, while another passage cites approximately $2.979 million, so the filing’s working-capital figure is inconsistent. Stockholders’ deficit was $12.096 million.
The $8.855 million deferred underwriting fee is payable from trust funds only if a business combination closes. The company also pays its sponsor $10,000 per month for office, support, and administrative services.
Outlook, risks, and unusual items
The independent auditor’s report expresses substantial doubt about the company’s ability to continue as a going concern. Management said it intended to complete a business combination before February 17, 2024, but acknowledged uncertainty about completing one and about funding operations through that date. Sponsor, officer, and director loans or other financing were possible but not committed. If no combination is completed by the deadline, the company must wind up and redeem public shares; warrants would expire worthless.
- Nasdaq listing: In January 2023, Nasdaq notified the company that it did not meet the minimum 500,000 publicly held shares requirement. The company submitted a compliance plan in March; acceptance and continued listing were uncertain.
- Redemptions and transaction financing: Further redemptions could leave too little cash to meet a target’s closing conditions or complete a transaction, potentially requiring additional financing or abandonment of a deal.
- Excise tax: The filing says post-2022 redemptions may be subject to the Inflation Reduction Act’s 1% excise tax, depending on the transaction and applicable guidance.
- Conflicts and dilution: Sponsor and management interests, competing fiduciary obligations, founder-share conversion adjustments, warrants, and potential new equity or debt could affect transaction terms and dilute public investors.
- Reporting controls: The filing discusses a previously identified material weakness in accounting for complex financial instruments and remediation efforts, but also states management concluded internal control over financial reporting was effective at year-end. Investors should review the related disclosures and their status.
- Other uncertainties: The company cites competition for targets, market and financing conditions, COVID-19, Russia’s invasion of Ukraine, third-party claims against trust assets, and warrant fair-value volatility.
Key facts investors should verify
- Confirm the filing entity: this is Rosecliff Acquisition Corp I, not Spectral AI, Inc.
- Check subsequent filings for the status of a business-combination search, the February 17, 2024 deadline, and any further extensions or redemptions.
- Verify Nasdaq’s response to the compliance plan and the company’s current listing status.
- Reconcile the reported working-capital deficit and assess available cash, accrued liabilities, and any financing actually committed.
- Review the accounting-control disclosures, including the prior material weakness, remediation, and management’s year-end effectiveness conclusion.